Search the Newsreel

Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical overview of Kenvue Inc (KVUE) dividends and stock splits, including past and upcoming payout dates and amounts. It lists the dividend record dates, payment dates, and ex-dividend dates, detailing both interim and final cash dividends. The document also …

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

An Illinois Appellate Court upheld a US$45 million verdict against Johnson & Johnson for asbestos-contaminated talc, also confirming Kenvue's successor liability. This ruling reinforces the ongoing legal exposure Kenvue faces due to legacy talc products, even as it pursues a merger with Kimberly Clark. …

US FDA approves over-the-counter Tylenol combination pill for pain relief

The U.S. Food and Drug Administration has approved an over-the-counter combination pill of Kenvue's Tylenol and naproxen for up to 12 hours of pain relief. This approval aligns with "The Great Healthcare Plan" to increase the availability of safe pharmaceutical drugs for OTC purchase. …

Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Kenvue Inc (KVUE), listing its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding data over several quarters historically, and recent shareholder activity by key institutions. The report also lists ETFs that …

Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE

Mizuho Markets Americas LLC significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 85.0% in the first quarter, selling over 12 million shares and now holding 2.1 million shares. Despite this, other institutional investors have either increased or initiated positions in Kenvue. The company …

Capula Management Ltd Grows Position in Kenvue Inc. $KVUE

Capula Management Ltd significantly increased its holdings in Kenvue Inc. (NYSE: KVUE) by 137.7% in the first quarter, now owning 2.25 million shares. This comes as Kenvue reported strong Q1 earnings, beating analyst estimates with an EPS of $0.32 and revenue of $3.91 billion, …

ENvue Medical deploys additional platform at Texas medical center

ENvue Medical (NASDAQ:FEED) has deployed an additional ENvue Navigation Platform at an academic medical center in the Dallas-Fort Worth Metroplex. This expansion signifies the successful adoption and effectiveness of the technology, which provides real-time bedside visualization for feeding tube placement. The company, headquartered in …

Kenvue Inc. stock falls Thursday, still outperforms market

Kenvue Inc. (KVUE) stock fell 1.20% on Thursday, closing at $18.90, despite a broader market downturn where the S&P 500 and Dow Jones Industrial Average also experienced declines. The company's stock still outperformed the overall market indices. Kenvue Inc. is currently 17.36% below its …

ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center

ENvue Medical, a commercial-stage medical device company, announced the deployment of an additional ENvue™ Navigation Platform at a major academic medical center in the Dallas-Fort Worth Metroplex. This expansion reflects increasing commercial demand for their bedside feeding tube navigation system, as the existing customer, …

Dallas-Fort Worth medical center adds bedside feeding-tube navigation

ENvue Medical (NASDAQ: FEED) announced the deployment of an additional ENvue™ Navigation Platform at a major academic medical center in the Dallas-Fort Worth Metroplex. This expansion signifies growing clinician adoption of their minimally invasive electromagnetic navigation system for real-time bedside feeding tube placement. The …

Kenvue to announce Q2 2026 results on August 6, 2026

Kenvue Inc. will release its Q2 2026 financial results before market open on August 6, 2026. The company will not hold a conference call due to a pending transaction with Kimberly-Clark, and the results will be available on its investor relations website. This announcement …

Kenvue Will Release Q2 Results Aug. 6 Without Conference Call

Kenvue Inc. (NYSE: KVUE) announced it will release its second quarter 2026 financial results on August 6, 2026, before the market opens. The company will not host a quarterly conference call due to a pending transaction with Kimberly-Clark. Results will be available on Kenvue's …

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

SUMMIT, N.J., July 23, 2026--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its …

Technical Reactions to KVUE Trends in Macro Strategies

This article provides a technical analysis of Kenvue Inc. (NASDAQ: KVUE), highlighting a strong near-term sentiment while mid and long-term outlooks are neutral. It identifies a significant risk-reward short setup and offers three institutional trading strategies tailored for different risk profiles and holding periods, …

Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts

Kenvue Inc. (NYSE:KVUE) has received an average "Hold" rating from sixteen analysts, with thirteen recommending a hold and three a buy. The average 1-year price target for the stock is $19.5833. Recent analyst commentary includes ratings cuts and increases, with the company reporting strong …

Kenvue broadens China focus on minor ailment management

Kenvue, a US-based consumer health company, is expanding its focus on minor ailment management in China due to rising health awareness and demand for self-care products. The company plans to broaden its product portfolio, enhance public health education, and collaborate with pharmacies and online …

SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE

SEB Asset Management AB has acquired a new position in Kenvue Inc. (NYSE:KVUE) during the first quarter, purchasing 437,872 shares valued at approximately $7.55 million. Kenvue reported strong Q1 results, exceeding EPS and revenue expectations, and declared a quarterly dividend of $0.2075 per share, …

Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE

Dimensional Fund Advisors LP significantly increased its stake in Kenvue Inc., now owning 22.27 million shares valued at $383.94 million. This comes after Kenvue beat earnings expectations with $3.91 billion in revenue and an EPS of $0.32, and the company offers an annualized dividend …

Nanoveu Limited (ASX:NVU) Returns to Traders' Radar as Edge-AI Story Gathers Pace

What to Expect From Kenvue’s Q2 2026 Earnings Report

Kenvue Inc. (KVUE), the world's largest pure-play consumer health company, is preparing to report its fiscal 2026 second-quarter results, with analysts expecting a 10.3% year-over-year increase in earnings per share to $0.32. Despite consistently beating earnings estimates, the stock has underperformed the broader market …

Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda

Kapitalo Investimentos Ltda significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 97.2% in the first quarter, selling 1,944,000 shares. Despite this sell-off, Kenvue reported stronger-than-expected quarterly results with EPS of $0.32 and revenue of $3.91 billion, a 4.5% year-over-year increase. The company offers …

Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE

The Swiss National Bank increased its stake in Kenvue Inc. by 6.9% during the first quarter, now owning 5,622,946 shares worth $96.94 million. Several other institutional investors also adjusted their positions in Kenvue, with significant increases from Independent Franchise Partners LLP, Sculptor Capital LP, …

Kenvue stock trades steadily as consumer health spin-off builds earnings record

Kenvue, the consumer health spin-off from Johnson & Johnson, has established its earnings record since its 2023 separation, reporting over $15 billion in revenue and initiating a regular dividend. The company's financials show stable operating margins and strong cash flow, with a focus on …

After Hours Most Active for Jul 20, 2026 : NVDA, CMCSA, INTC, HDB, KVUE, AAPL, WMT, PLTR, DVN, VZ, ESI, UPS

The NASDAQ 100 After Hours Indicator is down -13.85 to 28,590.38. The total After hours volume is currently 108,486,190 shares traded. The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is -0.78 at $202.50, with 4,403,392 shares traded. …

Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC

HSBC Holdings PLC increased its stake in Kenvue Inc. (NYSE:KVUE) by 10% in the first quarter, reaching 5.62 million shares worth approximately $96.6 million. Kenvue's recent earnings report beat expectations with an EPS of $0.32 and revenue of $3.91 billion, marking a 4.5% year-over-year …

Press Release: ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform

ENvue Medical has announced the appointment of a new Chairman of the Board and two new directors, significantly bolstering its leadership with expertise in clinical development, AI governance, and capital markets. Dr. Mark Kontrovitz, a board-certified ophthalmologist, will serve as Chairman, bringing extensive experience …

Listerine Cool Mint by Kenvue Inc. - mouthwash classic fuels recurring sales

Listerine Cool Mint, a classic mouthwash by Kenvue Inc., is a significant driver of recurring sales and a core product in the company's oral care portfolio. Its enduring popularity stems from its unique sensory profile, clinical backing for reducing plaque and gingivitis, and strong …

Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE

The Illinois Municipal Retirement Fund increased its stake in Kenvue Inc. by 12.7% in the first quarter, purchasing an additional 72,348 shares, bringing its total holdings to 643,141 shares valued at approximately $11.1 million. Kenvue recently reported strong quarterly results, surpassing EPS estimates with …

How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story

A recent Illinois Appellate Court ruling has upheld a $45 million jury verdict against Johnson & Johnson and its successors, Kenvue Inc. and Johnson & Johnson Holdco (NA) Inc., confirming liability for asbestos-contaminated talc. This decision affirming successor liability following J&J's consumer business restructuring …

Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE

Blackhawk Capital Partners LLC has acquired a new stake in Kenvue Inc., purchasing 96,412 shares valued at approximately $1.66 million during the first quarter. Despite high institutional ownership and Kenvue beating recent earnings and revenue estimates, analyst sentiment remains cautious with a "Hold" consensus …

Nanoveu Limited Initiates Trading Halt Ahead of Key Drone Performance Results

Kenvue’s 5.6% week draws 147.5M shares as price reaches Fair Value

Kenvue finished the week at $19.13, just above Sharemaestro Fair Value, with improved participation and an active Trend backdrop. The read is constructive, but Relative Strength has not yet turned positive.

Price to earnings forward of ENvue Medical, Inc. – NASDAQ:FEED

FEED Q1 2026 Earnings: Deep Losses and Steep Sell-Off Highlight Operational Headwinds - Revenue Growth Report

FEED Q1 2026 Earnings: Significant Loss Reported, Stock Declines - One-Time Gain Impact

ENvue Medical’s US Hospital Expansion Sparks Growth Speculation